Economic Comparison of Leflunomide and Methotrexate in Patients with Rheumatoid Arthritis: An Evaluation Based on a 1-Year Randomised Controlled Trial

Author： Maetzel A.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.20, Iss.1, 2002-01, pp. : 61-70

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety evaluation of leflunomide in rheumatoid arthritis

By I Keen Helen  

Expert Opinion on Drug Safety, Vol. 12, Iss. 4, 2013-07 ,pp. : 581-588

Informa Healthcare

Access to resources Recommend Favorite

Semiphysiologically Based Pharmacokinetic Model of Leflunomide Disposition in Rheumatoid Arthritis Patients

By  

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 4, Iss. 6, 2015-06 ,pp. : 362-371

John Wiley & Sons Inc

Access to resources Recommend Favorite

Validation of the Methotrexate‐First Strategy in Patients With Early, Poor‐Prognosis Rheumatoid Arthritis: Results From a Two‐Year Randomized, Double‐Blind Trial

By  

Arthritis & Rheumatism, Vol. 65, Iss. 8, 2013-08 ,pp. : 1985-1994

John Wiley & Sons Inc

Access to resources Recommend Favorite

Leflunomide for the treatment of rheumatoid arthritis

By Miceli-Richard Corinne   Dougados Maxime  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 6, 2003-06 ,pp. : 987-997

Informa Healthcare

Access to resources Recommend Favorite

Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate

By  

Arthritis & Rheumatism, Vol. 48, Iss. 10, 2003-10 ,pp. : 2763-2768

John Wiley & Sons Inc

Access to resources Recommend Favorite